CB1 receptor — Drug Target

3 drugs 1 in Phase 3

All drugs that target CB1 receptor — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

cannabinoid · CB1 receptor agonist · Cannabinoid

Phase 3 pipeline (1)

SP-102 · Scilex Pharmaceuticals, Inc. · cannabinoid · Pain
SP-102 is a synthetic version of delta-9-tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis.

Phase 2 pipeline (2)

DMXB-A · CoMentis · CB1 receptor agonist · Neurology
DMXB-A is a potent agonist of the CB1 receptor.
Full-Spectrum Cannabidiol · Staci Gruber, Ph.D. · Cannabinoid · Neurology
Cannabidiol acts as a CB1 receptor antagonist